Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation54

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation20

Views

Views
April 20252
May 20250
June 20250
July 202516
August 20250
September 20252
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States5
Argentina3
Canada1
Spain1
United Kingdom1
Morocco1
Paraguay1
 

Top cities views

Views
Córdoba2
Asunción1
Council Bluffs1
Dallas1
Guarujá1
Oujda1
Pelotas1
Saint-Jean-sur-Richelieu1
Salvador1
São Gonçalo1